Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy.
Hsu
Chiun
C
Wei
Shu-Chen
SC
Cheng
Ann-Lii
AL
Chen
Pei-Jer
PJ
D006509:Hepatitis B / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D055502:Secondary Prevention
D007166:Immunosuppressive Agents